Mott poised to be among first in the nation to offer groundbreaking CAR-T cell therapy for childhood leukemia
The U.S. Food and Drug Administration on Aug.30 approved the first-ever gene therapy to treat children and young adults with leukemia.
The U.S. Food and Drug Administration on Aug.30 approved the first-ever gene therapy to treat children and young adults with leukemia.